Showing 661 - 680 results of 31,017 for search '(( significant decrease decrease ) OR ( significant ((change increases) OR (larger decrease)) ))', query time: 0.48s Refine Results
  1. 661
  2. 662

    Image 2_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg by Joseph W. P. Nakoa (21796214)

    Published 2025
    “…Microbial community structure was characterized using 16S rRNA gene sequencing, at three time points, before, during, and after the sedimentation event, to identify changes in microbial composition and diversity.</p>Results<p>Sedimentation caused a significant decline in microbial diversity and shifted community composition, with the most pronounced changes observed post-sedimentation. …”
  3. 663

    Image 3_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg by Joseph W. P. Nakoa (21796214)

    Published 2025
    “…Microbial community structure was characterized using 16S rRNA gene sequencing, at three time points, before, during, and after the sedimentation event, to identify changes in microbial composition and diversity.</p>Results<p>Sedimentation caused a significant decline in microbial diversity and shifted community composition, with the most pronounced changes observed post-sedimentation. …”
  4. 664

    Image 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg by Joseph W. P. Nakoa (21796214)

    Published 2025
    “…Microbial community structure was characterized using 16S rRNA gene sequencing, at three time points, before, during, and after the sedimentation event, to identify changes in microbial composition and diversity.</p>Results<p>Sedimentation caused a significant decline in microbial diversity and shifted community composition, with the most pronounced changes observed post-sedimentation. …”
  5. 665

    Table 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.xlsx by Joseph W. P. Nakoa (21796214)

    Published 2025
    “…Microbial community structure was characterized using 16S rRNA gene sequencing, at three time points, before, during, and after the sedimentation event, to identify changes in microbial composition and diversity.</p>Results<p>Sedimentation caused a significant decline in microbial diversity and shifted community composition, with the most pronounced changes observed post-sedimentation. …”
  6. 666

    Data Sheet 1_Bio-functional hydrogel coated membranes to decrease T-cell exhaustion in manufacturing of CAR T-cells.docx by Aida López Ruiz (21611177)

    Published 2025
    “…Additionally, increased T-cell transduction and decreased exhaustion for the CAR T population were observed with HCMs. …”
  7. 667

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
  8. 668
  9. 669
  10. 670

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  11. 671

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  12. 672
  13. 673
  14. 674
  15. 675
  16. 676
  17. 677
  18. 678
  19. 679
  20. 680